Israel Gp Ltd. Orbimed's Net Worth

Israel Gp Ltd. Orbimed's net worth is estimated to be at least $21,698,495.96 as of 11/23/2024. CoreStreet's estimation of Israel Gp Ltd. Orbimed's net worth is based on their sale of stock and current holding of stock.

Israel Gp Ltd. Orbimed is Major Shareholder at Chemomab Therapeutics Ltd DRC. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 336,900 units of CMMB stock on 01/03/2023. Their biggest sale was on 06/25/2021 when they sold 15,989,876 units of 9 Meters Biopharma Inc stock for $19,347,749.96. They typically trade 1 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $21,698,495.96
Most recent insider trade:
  • Jan. 3, 2023

Israel Gp Ltd. Orbimed's Insider Trading History

Chemomab Therapeutics Ltd DRCTitleAmountPriceTypeTotal Value
Jan. 3, 2023
Major Shareholder336,900$3.58Sell$1,206,102.00
9 Meters Biopharma IncTitleAmountPriceTypeTotal Value
June 25, 2021
Major Shareholder15,989,876$1.21Sell$19,347,749.96
June 23, 2021
Major Shareholder841,650$1.36Sell$1,144,644.00